Spectra for:
Jinkai Zheng, Zhihong Xu, Yi Wang, Kui Hong, Peipei Liu, Weiming Zhu
Compound 1 SCLEROTIOTIDE_A;(2-E,4-E,6-E)-CYCLO-[(N-ME-L-ALA)-L-VAL-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]
![SCLEROTIOTIDE_A;(2-E,4-E,6-E)-CYCLO-[(N-ME-L-ALA)-L-VAL-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]](/api/compound/90RpsMtdt3c.png?h=300&w=458 "SCLEROTIOTIDE_A;(2-E,4-E,6-E)-CYCLO-[(N-ME-L-ALA)-L-VAL-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]")
Compound 2 SCLEROTIOTIDE_B;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]
![SCLEROTIOTIDE_B;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]](/api/compound/JqXlZ5vlDvx.png?h=300&w=458 "SCLEROTIOTIDE_B;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]")
Compound 3 SCLEROTIOTIDE_C;(2-E,4-E,6-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-LYS)]
![SCLEROTIOTIDE_C;(2-E,4-E,6-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-LYS)]](/api/compound/1MT6a9ieEtc.png?h=300&w=458 "SCLEROTIOTIDE_C;(2-E,4-E,6-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-LYS)]")
Compound 4 SCLEROTIOTIDE_D;(2-E,4-E,6-Z)-CYCLO-[L-ALA-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]
![SCLEROTIOTIDE_D;(2-E,4-E,6-Z)-CYCLO-[L-ALA-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]](/api/compound/6VCmfLQS5ey.png?h=300&w=458 "SCLEROTIOTIDE_D;(2-E,4-E,6-Z)-CYCLO-[L-ALA-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]")
Compound 5 SCLEROTIOTIDE_E;(2-E,4-E,6-Z)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]
![SCLEROTIOTIDE_E;(2-E,4-E,6-Z)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]](/api/compound/KHbtyKaVq7Y.png?h=300&w=458 "SCLEROTIOTIDE_E;(2-E,4-E,6-Z)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-OCTA-2,4,6-TRIENOYL-L-ORN)]")
Compound 6 SCLEROTIOTIDE_F;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-(ALPHA)-6-OXOHEXA-2,4-DIENOYL-L-ORN)]
![SCLEROTIOTIDE_F;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-(ALPHA)-6-OXOHEXA-2,4-DIENOYL-L-ORN)]](/api/compound/VUKnRqmxOp.png?h=300&w=458 "SCLEROTIOTIDE_F;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-(ALPHA)-6-OXOHEXA-2,4-DIENOYL-L-ORN)]")
Compound 7 SCLEROTIOTIDE_G;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-7-HYDROXY-6-OXOOCTA-2,4-DIENOYL-L-ORN)]
![SCLEROTIOTIDE_G;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-7-HYDROXY-6-OXOOCTA-2,4-DIENOYL-L-ORN)]](/api/compound/KX6RBR2zcyC.png?h=300&w=458 "SCLEROTIOTIDE_G;(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-7-HYDROXY-6-OXOOCTA-2,4-DIENOYL-L-ORN)]")
Compound 8 SCLEROTIOTIDE_H;THREO-(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-6,7-DIHYDROXYOCTA-2,4-DIENOYL-L-ORN)]
![SCLEROTIOTIDE_H;THREO-(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-6,7-DIHYDROXYOCTA-2,4-DIENOYL-L-ORN)]](/api/compound/LU2EPVDAlMt.png?h=300&w=458 "SCLEROTIOTIDE_H;THREO-(2-E,4-E)-CYCLO-[(N-ME-L-ALA)-(N-ME-L-VAL)-(N-ALPHA-6,7-DIHYDROXYOCTA-2,4-DIENOYL-L-ORN)]")
Compound 13 ASPOCHRACIN
Citation
| Citation | J.NAT.PROD.,73,1133(2010) |
|---|---|
| Journal | Journal of Natural Products |
| Issue | 6 |
| Volume | 73 |
| Page(s) | 1133-1137 |
| Year | 2010 |
| Author(s) | Jinkai Zheng, Zhihong Xu, Yi Wang, Kui Hong, Peipei Liu, Weiming Zhu |
| Publisher | American Chemical Society (ACS) |
| DOI | 10.1021/np100198h |